STATCenter·
STAT+: Expert warns of battleground over global access to newer GLP-1 drugs for obesity
How obesity medications may become the next big battleground over access to medicines in lower-income countries.
Read at STAT →
How obesity medications may become the next big battleground over access to medicines in lower-income countries.

<iframe src="https://statesidedaily.com/embed/cluster/444c033abbcf97f06d10519fcbb6c960e0015be1" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: Expert warns of battleground over global access to newer GLP-1 drugs for obesity"></iframe>